Is hepatic steatosis associated with left ventricular mass index increase in the general population?

Figure 3 Path model for the effects of hepatic steatosis via systolic and diastolic blood pressure on left ventricular mass index in the subgroup of individuals without medication (n = 811). χ² = 1.9, df = 3, P = 0.60; RMSEA < 0.01; CFI > 0.99. Indirect Effect via BPsys0: β = -0.30; s.e. = 0.17; P = 0.07; Indirect Effect via BPdia0: β = 0.15; s.e. = 0.14; P = 0.30. FLD: Fatty liver disease; LVMI: Left ventricular mass index; BPsys: Systolic blood pressure; BPdia: Diastolic blood pressure; RMSEA: Root mean square error; CFI: Comparative fit index; s.e.: Standard error.